Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10549)
All Articles published online
|
Publishing Process of This Article
|
Aug 7, 2018 (publication date) through Jun 6, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Adamska A, Falasca M. ATP-binding cassette transporters in progression and clinical outcome of pancreatic cancer: What is the way forward? World J Gastroenterol 2018; 24(29): 3222-3238 [PMID: 30090003 DOI: 10.3748/wjg.v24.i29.3222] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v24/i29/3222.htm |
| Number | Citing Articles |
| 1 |
Guangping Chen. An Introduction to Interdisciplinary Toxicology. 2020; : 31 doi: 10.1016/B978-0-12-813602-7.00003-X
|
| 2 |
Yashi Verma, Anamika Yadav, Pramod Katara. Mining of cancer core-genes and their protein interactome using expression profiling based PPI network approach. Gene Reports 2020; 18: 100583 doi: 10.1016/j.genrep.2019.100583
|
| 3 |
Victoria Abzianidze, Natalia Moiseeva, Diana Suponina, Sofya Zakharenkova, Nadezhda Rogovskaya, Lidia Laletina, Alvin A. Holder, Denis Krivorotov, Alexander Bogachenkov, Alexander Garabadzhiu, Anton Ukolov, Vyacheslav Kosorukov. Natural Phaeosphaeride A Derivatives Overcome Drug Resistance of Tumor Cells and Modulate Signaling Pathways. Pharmaceuticals 2022; 15(4): 395 doi: 10.3390/ph15040395
|
| 4 |
Tomas Koltai, Stephan Joel Reshkin, Tiago M. A. Carvalho, Daria Di Molfetta, Maria Raffaella Greco, Khalid Omer Alfarouk, Rosa Angela Cardone. Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma: A Physiopathologic and Pharmacologic Review. Cancers 2022; 14(10): 2486 doi: 10.3390/cancers14102486
|
| 5 |
Yuki Denda, Yoichi Matsuo, Saburo Sugita, Yuki Eguchi, Keisuke Nonoyama, Hiromichi Murase, Tomokatsu Kato, Hiroyuki Imafuji, Kenta Saito, Mamoru Morimoto, Ryo Ogawa, Hiroki Takahashi, Akira Mitsui, Masahiro Kimura, Shuji Takiguchi. The Natural Product Parthenolide Inhibits Both Angiogenesis and Invasiveness and Improves Gemcitabine Resistance by Suppressing Nuclear Factor κB Activation in Pancreatic Cancer Cell Lines. Nutrients 2024; 16(5): 705 doi: 10.3390/nu16050705
|
| 6 |
Katja Zappe, Margit Cichna-Markl. Aberrant DNA Methylation of ABC Transporters in Cancer. Cells 2020; 9(10): 2281 doi: 10.3390/cells9102281
|
| 7 |
Alejandro Carozzo, Agustín Yaneff, Natalia Gómez, Nicolás Di Siervi, Ana Sahores, Federico Diez, Alejandra I. Attorresi, Ángela Rodríguez-González, Federico Monczor, Natalia Fernández, Martín Abba, Carina Shayo, Carlos Davio. Identification of MRP4/ABCC4 as a Target for Reducing the Proliferation of Pancreatic Ductal Adenocarcinoma Cells by Modulating the cAMP Efflux. Molecular Pharmacology 2019; 96(1): 13 doi: 10.1124/mol.118.115444
|
| 8 |
Shizheng Li, Chunxia Wu, Chenxing Fan, Puwei Zhang, Guifa Yu, Kun Li. Tanshinone II A improves the chemosensitivity of breast cancer cells to doxorubicin by inhibiting β‐catenin nuclear translocation. Journal of Biochemical and Molecular Toxicology 2021; 35(1) doi: 10.1002/jbt.22620
|
| 9 |
Xin-Wei Li, Ming-Yuan Zhang, Zhi-Jun Li, Li-Zhe Ai, Meng-Di Jin, Ning-Ning Jia, Meng-Tong Xie, Yu-Qing Yang, Wei-Zhen Li, Lin Dong, Qiong Yu. <i>ABCB9</i> polymorphism rs61955196 is associated with schizophrenia in a Chinese Han population. World Journal of Psychiatry 2022; 12(7): 904-914 doi: 10.5498/wjp.v12.i7.904
Abstract(283) |
Core Tip(330) |
Full Article(HTML)(1352)
|
Full Article (PDF)-809K(125)
|
Full Article (Word)-213K(40)
|
Audio-2725K(1)
|
Peer-Review Report-226K(48)
|
Answering Reviewers-208K(49)
|
Times Cited (0)
|
Total Visits (4188)
|
Open
|
| 10 |
Ji He, Piyush Bugde, Jiawei Li, Riya Biswas, Siting Li, Xuewei Yang, Fang Tian, Zimei Wu, Yan Li. Multidrug resistance protein 5 affects cell proliferation, migration and gemcitabine sensitivity in pancreatic cancer MIA Paca‑2 and PANC‑1 cells. Oncology Reports 2023; 51(1) doi: 10.3892/or.2023.8666
|
| 11 |
Sven Marcel Stefan. Multi-Target ABC Transporter Modulators: What Next and Where to Go?. Future Medicinal Chemistry 2019; 11(18): 2353 doi: 10.4155/fmc-2019-0185
|
| 12 |
Pérez-De Marcos Juan-Carlos, Pérez-Pineda Perla-Lidia, Méndez-Morales Stephanie-Talia, Arellano-Mendoza Mónica-Griselda, Torres-Espíndola Luz-María. ABC transporter superfamily. An updated overview, relevance in cancer multidrug resistance and perspectives with personalized medicine. Molecular Biology Reports 2021; 48(2): 1883 doi: 10.1007/s11033-021-06155-w
|
| 13 |
Lei Kong, Jiali Du, Jichun Gu, Junyuan Deng, Yujie Guo, Baian Tao, Chen Jin, Deliang Fu, Ji Li. Gemcitabine-Loaded Albumin Nanoparticle Exerts An Antitumor Effect on Gemcitabine-Resistant Pancreatic Cancer Cells Induced by MDR1 and MRP1 Overexpression in Vitro. Frontiers in Surgery 2022; 9 doi: 10.3389/fsurg.2022.890412
|
| 14 |
Cordula Stillhart, Katarina Vučićević, Patrick Augustijns, Abdul W. Basit, Hannah Batchelor, Talia R. Flanagan, Ina Gesquiere, Rick Greupink, Daniel Keszthelyi, Mikko Koskinen, Christine M. Madla, Christophe Matthys, Goran Miljuš, Miriam G. Mooij, Neil Parrott, Anna-Lena Ungell, Saskia N. de Wildt, Mine Orlu, Sandra Klein, Anette Müllertz. Impact of gastrointestinal physiology on drug absorption in special populations––An UNGAP review. European Journal of Pharmaceutical Sciences 2020; 147: 105280 doi: 10.1016/j.ejps.2020.105280
|
| 15 |
Andreia S. Barros, Elisabete C. Costa, Ana S. Nunes, Duarte de Melo-Diogo, Ilídio J. Correia. Comparative study of the therapeutic effect of Doxorubicin and Resveratrol combination on 2D and 3D (spheroids) cell culture models. International Journal of Pharmaceutics 2018; 551(1-2): 76 doi: 10.1016/j.ijpharm.2018.09.016
|
| 16 |
Wenjing Wang, Shubin Niu, Luxin Qiao, Feili Wei, Jiming Yin, Shanshan Wang, Yabo Ouyang, Dexi Chen. Usnea Acid as Multidrug Resistance (MDR) Reversing Agent against Human Chronic Myelogenous Leukemia K562/ADR Cells via an ROS Dependent Apoptosis. BioMed Research International 2019; 2019: 1 doi: 10.1155/2019/8727935
|
| 17 |
Aikaterini Emmanouilidi, Ilaria Casari, Begum Gokcen Akkaya, Tania Maffucci, Luc Furic, Federica Guffanti, Massimo Broggini, Xi Chen, Yulia Y. Maxuitenko, Adam B. Keeton, Gary A. Piazza, Kenneth J. Linton, Marco Falasca. Inhibition of the Lysophosphatidylinositol Transporter ABCC1 Reduces Prostate Cancer Cell Growth and Sensitizes to Chemotherapy. Cancers 2020; 12(8): 2022 doi: 10.3390/cancers12082022
|
| 18 |
Aferin Beilerli, Ilgiz Gareev, Ozal Beylerli, Guang Yang, Valentin Pavlov, Gjumrakch Aliev, Aamir Ahmad. Circular RNAs as biomarkers and therapeutic targets in cancer. Seminars in Cancer Biology 2022; 83: 242 doi: 10.1016/j.semcancer.2020.12.026
|
| 19 |
Xinpeng Yin, Ruiyuan Xu, Jianlu Song, Rexiati Ruze, Yuan Chen, Chengcheng Wang, Qiang Xu. Lipid metabolism in pancreatic cancer: emerging roles and potential targets. Cancer Communications 2022; 42(12): 1234 doi: 10.1002/cac2.12360
|
| 20 |
Ok Jeong Moon, Chul Joo Yoon, Jun Soo Lee, Hye Hyun Kim, Yong Hwan Seol, Jeewon Lee. Tumor-specific release of copper-incorporated diethyldithiocarbamate from an optimized apoferritin scaffold enables both potent and safe anti-cancer therapy. Chemical Engineering Journal 2023; 473: 145176 doi: 10.1016/j.cej.2023.145176
|
| 21 |
Coix Seed Extract Enhances the Anti-Pancreatic Cancer Efficacy of Gemcitabine through Regulating ABCB1- and ABCG2-Mediated Drug Efflux: A Bioluminescent Pharmacokinetic and Pharmacodynamic Study. International Journal of Molecular Sciences 2019; 20(21): 5250 doi: 10.3390/ijms20215250
|
| 22 |
Wei Huang, Shu Yang, Yu-Shan Cheng, Ni Sima, Wei Sun, Min Shen, John C. Braisted, Weiguo Lu, Wei Zheng. Terfenadine resensitizes doxorubicin activity in drug-resistant ovarian cancer cells via an inhibition of CaMKII/CREB1 mediated ABCB1 expression. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.1068443
|
| 23 |
Zhiyu Zhao, Arshdeep Khurana, Frank Antony, John W. Young, Keeley G. Hewton, Zora Brough, Tianshuang Zhong, Seth J. Parker, Franck Duong van Hoa. A Peptidisc-Based Survey of the Plasma Membrane Proteome of a Mammalian Cell. Molecular & Cellular Proteomics 2023; 22(8): 100588 doi: 10.1016/j.mcpro.2023.100588
|
| 24 |
Huan Xiao, Yongcheng Zheng, Lingling Ma, Lili Tian, Qiu Sun. Clinically-Relevant ABC Transporter for Anti-Cancer Drug Resistance. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.648407
|
| 25 |
Manuel Gentiluomo, Paula Puchalt García, Alice Alessandra Galeotti, Renata Talar-Wojnarowska, Christine Tjaden, Francesca Tavano, Oliver Strobel, Juozas Kupcinskas, John Neoptolemos, Péter Hegyi, Eithne Costello, Raffaele Pezzilli, Cosimo Sperti, Rita T Lawlor, Gabriele Capurso, Andrea Szentesi, Pavel Soucek, Pavel Vodicka, Martin Lovecek, Thilo Hackert, Giulia Martina Cavestro, Anna Caterina Milanetto, Federico Canzian, Daniele Campa. Genetic variability of the ABCC2 gene and clinical outcomes in pancreatic cancer patients. Carcinogenesis 2019; 40(4): 544 doi: 10.1093/carcin/bgz006
|
| 26 |
Wei Wang, Ze Liang, Pengfei Ma, Qi Zhao, Mengyuan Dai, Jie Zhu, Xu Han, Hong Xu, Qingyan Chang, Yuhong Zhen. Application of CRISPR/Cas9 System to Reverse ABC-Mediated Multidrug Resistance. Bioconjugate Chemistry 2021; 32(1): 73 doi: 10.1021/acs.bioconjchem.0c00627
|
| 27 |
Neda Gholamian Dehkordi, Seyed Abbas Mirzaei, Fatemeh Elahian. Pharmacodynamic mechanisms of anti-inflammatory drugs on the chemosensitization of multidrug-resistant cancers and the pharmacogenetics effectiveness. Inflammopharmacology 2021; 29(1): 49 doi: 10.1007/s10787-020-00765-9
|
| 28 |
Viktória Buľková, Jana Vargová, Marián Babinčák, Rastislav Jendželovský, Zbyněk Zdráhal, Pavel Roudnický, Ján Košuth, Peter Fedoročko. New findings on the action of hypericin in hypoxic cancer cells with a focus on the modulation of side population cells. Biomedicine & Pharmacotherapy 2023; 163: 114829 doi: 10.1016/j.biopha.2023.114829
|
| 29 |
Joanna Korszun. The development of multidrug resistance in cancer cells: the potential of ABC transporter-targeted therapy to overcome inefficiency of treatment. Acta Universitatis Lodziensis. Folia Biologica et Oecologica 2021; 17: 7 doi: 10.18778/1730-2366.16.04
|
| 30 |
Aiste Gulla, Urte Andriusaityte, Gabrielius Zdanys, Elena Babonaite, Kestutis Strupas, Helena Kelly. The Impact of Epithelial–Mesenchymal Transition and Metformin on Pancreatic Cancer Chemoresistance: A Pathway towards Individualized Therapy. Medicina 2022; 58(4): 467 doi: 10.3390/medicina58040467
|
| 31 |
Sumel Ashique, Mithun Bhowmick, Radheshyam Pal, Heya Khatoon, Prashant Kumar, Himanshu Sharma, Ashish Garg, Shubneesh Kumar, Ushasi Das. Multi drug resistance in Colorectal Cancer- approaches to overcome, advancements and future success. Advances in Cancer Biology - Metastasis 2024; 10: 100114 doi: 10.1016/j.adcanc.2024.100114
|
| 32 |
Matvey M. Tsyganov, Marina K. Ibragimova, Kseniya A. Gaptulbarova, Irina A. Tsydenova, Daria S. Dolgasheva, Evgeniy Y. Garbukov, Anastasia A. Frolova, Elena M. Slonimskaya, Nikolai V. Litvyakov. DNA Copy Number Aberrations and Expression of ABC Transporter Genes in Breast Tumour: Correlation with the Effect of Neoadjuvant Chemotherapy and Prognosis of the Disease. Pharmaceutics 2022; 14(5): 948 doi: 10.3390/pharmaceutics14050948
|
| 33 |
Michela Pasello, Anna Maria Giudice, Camilla Cristalli, Maria Cristina Manara, Caterina Mancarella, Alessandro Parra, Massimo Serra, Giovanna Magagnoli, Florencia Cidre-Aranaz, Thomas G. P. Grünewald, Carla Bini, Pier-Luigi Lollini, Alessandra Longhi, Davide Maria Donati, Katia Scotlandi. ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axis. Cellular Oncology 2022; 45(6): 1237 doi: 10.1007/s13402-022-00713-5
|
| 34 |
Yu-Ning Teng, Li-Hung Chen, Yi-Hung Chen (kui vavulengan). Repositioning application of polyoxyethylene (20) sorbitan monooleate on ocular drug resistance and cancer multi-drug resistance by inhibiting the ATPase activity of human multidrug resistance protein 1 and P-glycoprotein. European Journal of Pharmaceutics and Biopharmaceutics 2022; 170: 77 doi: 10.1016/j.ejpb.2021.12.002
|
| 35 |
Raúl Muñoz Velasco, Paula Jiménez Sánchez, Ana García García, Raquel Blanco Martinez-Illescas, Ángela Pastor Senovilla, Marian Lozano Yagüe, Alfonsina Trento, Rosa María García-Martin, Diego Navarro, Bruno Sainz, José Luis Rodríguez Peralto, Víctor Javier Sánchez-Arévalo Lobo. Targeting BPTF Sensitizes Pancreatic Ductal Adenocarcinoma to Chemotherapy by Repressing ABC-Transporters and Impairing Multidrug Resistance (MDR). Cancers 2022; 14(6): 1518 doi: 10.3390/cancers14061518
|
| 36 |
Xiaofang Luo, Ye Wu, Xiaokun Zhang, Min Tang, Feiye Ju, Zuodong Qin, Gregory J Duns, Wei-Dong Zhang, Jiang-Jiang Qin, Xin Luan. Peptide-based strategies for overcoming multidrug-resistance in cancer therapy. Chinese Chemical Letters 2024; : 109724 doi: 10.1016/j.cclet.2024.109724
|
| 37 |
Lynne W. Elmore, Susanna F. Greer, Elvan C. Daniels, Charles C. Saxe, Michael H. Melner, Ginger M. Krawiec, William G. Cance, William C. Phelps. Blueprint for cancer research: Critical gaps and opportunities. CA: A Cancer Journal for Clinicians 2021; 71(2): 107 doi: 10.3322/caac.21652
|
| 38 |
Chunmei Yang, Hui Yuan, Jinyang Gu, Dengfei Xu, Mingwei Wang, Jie Qiao, Xi Yang, Jian Zhang, Ming Yao, Jianren Gu, Hong Tu, Yu Gan. ABCA8-mediated efflux of taurocholic acid contributes to gemcitabine insensitivity in human pancreatic cancer via the S1PR2-ERK pathway. Cell Death Discovery 2021; 7(1) doi: 10.1038/s41420-020-00390-z
|
| 39 |
Petra Grbčić, Mirela Sedić. Sphingosine 1-Phosphate Signaling and Metabolism in Chemoprevention and Chemoresistance in Colon Cancer. Molecules 2020; 25(10): 2436 doi: 10.3390/molecules25102436
|
| 40 |
Xi Wu, Yangyang Han, Xiangyu Zhu, Alia Shah, Wei Wang, Yibao Sheng, Tingting Fan, Shuqing Cao. Negative regulation of cadmium tolerance in Arabidopsis by MMDH2. Plant Molecular Biology 2019; 101(4-5): 507 doi: 10.1007/s11103-019-00923-w
|
| 41 |
Silvia Di Giacomo, Marco Gullì, Roberta Facchinetti, Marco Minacori, Romina Mancinelli, Ester Percaccio, Caterina Scuderi, Margherita Eufemi, Antonella Di Sotto. Sorafenib Chemosensitization by Caryophyllane Sesquiterpenes in Liver, Biliary, and Pancreatic Cancer Cells: The Role of STAT3/ABC Transporter Axis. Pharmaceutics 2022; 14(6): 1264 doi: 10.3390/pharmaceutics14061264
|
| 42 |
Lin Hou, Xueying Zhang, Yan Jiao, Yanqing Li, Yuechen Zhao, Yinuo Guan, Ziling Liu. ATP binding cassette subfamily B member 9 (ABCB9) is a prognostic indicator of overall survival in ovarian cancer. Medicine 2019; 98(19): e15698 doi: 10.1097/MD.0000000000015698
|
| 43 |
Sara Taha, Elif Akova, Maximilian Michael Saller, Riccardo Enzo Giunta, Elisabeth Maria Haas-Lützenberger. Early Transcriptional Changes of Adipose-Derived Stem Cells (ADSCs) in Cell Culture. Medicina 2022; 58(9): 1249 doi: 10.3390/medicina58091249
|
| 44 |
Yunqing Li, Marianna Inglese, Suraiya Dubash, Chris Barnes, Diana Brickute, Marta Costa Braga, Ning Wang, Alice Beckley, Kathrin Heinzmann, Louis Allott, Haonan Lu, Cen Chen, Ruisi Fu, Laurence Carroll, Eric O. Aboagye. Consideration of Metabolite Efflux in Radiolabelled Choline Kinetics. Pharmaceutics 2021; 13(8): 1246 doi: 10.3390/pharmaceutics13081246
|
| 45 |
Aleksandra Adamska, Riccardo Ferro, Rossano Lattanzio, Emily Capone, Alice Domenichini, Verena Damiani, Giovanna Chiorino, Begum Gokcen Akkaya, Kenneth J. Linton, Vincenzo De Laurenzi, Gianluca Sala, Marco Falasca. ABCC3 is a novel target for the treatment of pancreatic cancer. Advances in Biological Regulation 2019; 73: 100634 doi: 10.1016/j.jbior.2019.04.004
|
| 46 |
S. V. Boichuk, T. V. Ivoilova. The role of ABC-transporters in homeostasis, cancer pathogenesis and therapy. Advances in Molecular Oncology 2024; 11(1): 8 doi: 10.17650/2313-805X-2024-11-1-8-21
|
| 47 |
Shiva Ganjali, Maciej Banach, Matteo Pirro, Zlatko Fras, Amirhossein Sahebkar. HDL and cancer - causality still needs to be confirmed? Update 2020. Seminars in Cancer Biology 2021; 73: 169 doi: 10.1016/j.semcancer.2020.10.007
|
| 48 |
Houriiyah Tegally, Kevin H. Kensler, Zahra Mungloo-Dilmohamud, Anisah W. Ghoorah, Timothy R. Rebbeck, Shakuntala Baichoo, Sophia N. Karagiannis. Discovering novel driver mutations from pan-cancer analysis of mutational and gene expression profiles. PLOS ONE 2020; 15(11): e0242780 doi: 10.1371/journal.pone.0242780
|
| 49 |
Miwako Omori, Rintaro Noro, Masahiro Seike, Kuniko Matsuda, Mariko Hirao, Aya Fukuizumi, Natsuki Takano, Akihiko Miyanaga, Akihiko Gemma. Inhibitors of ABCB1 and ABCG2 overcame resistance to topoisomerase inhibitors in small cell lung cancer. Thoracic Cancer 2022; 13(15): 2142 doi: 10.1111/1759-7714.14527
|
| 50 |
Hua-Ying Du, Yu-Zhou Zhang, Kuo Liu, Pei-Wen Gu, Shuang Cao, Xiang Gao, Zhi-Ying Wang, Zhi-Hua Liu, Ze-Yang Yu. Analysis of the Properties of 44 ABC Transporter Genes from Biocontrol Agent Trichoderma asperellum ACCC30536 and Their Responses to Pathogenic Alternaria alternata Toxin Stress. Current Issues in Molecular Biology 2023; 45(2): 1570 doi: 10.3390/cimb45020101
|
| 51 |
Yan-Qing Li, Megumi Murakami, Yang-Hui Huang, Tai-Ho Hung, Shun-Ping Wang, Yu-Shan Wu, Suresh V. Ambudkar, Chung-Pu Wu. Hydroxygenkwanin Improves the Efficacy of Cytotoxic Drugs in ABCG2-Overexpressing Multidrug-Resistant Cancer Cells. International Journal of Molecular Sciences 2022; 23(21): 12763 doi: 10.3390/ijms232112763
|
| 52 |
Muhammad Naveed, Muhammad Waseem, Izma Mahkdoom, Nouman Ali, Farrukh Asif, Jawad ul Hassan, Hamza Jamil. Transient comparison of techniques to counter multi-drug resistant bacteria: prime modules in curation of bacterial infections. Frontiers in Antibiotics 2024; 2 doi: 10.3389/frabi.2023.1309107
|
| 53 |
Christopher Gromisch, Motaz Qadan, Mariana Albuquerque Machado, Kebin Liu, Yolonda Colson, Mark W. Grinstaff. Pancreatic Adenocarcinoma: Unconventional Approaches for an Unconventional Disease. Cancer Research 2020; 80(16): 3179 doi: 10.1158/0008-5472.CAN-19-2731
|
| 54 |
Malek Zihlif, Tareq Hameduh, Nailya Bulatova, Hana Hammad. Alteration in the expression of the chemotherapy resistance‑related genes in response to chronic and acute hypoxia in pancreatic cancer. Biomedical Reports 2023; 19(6) doi: 10.3892/br.2023.1670
|
| 55 |
Vigneshwaran Namasivayam, Katja Silbermann, Jens Pahnke, Michael Wiese, Sven Marcel Stefan. Scaffold fragmentation and substructure hopping reveal potential, robustness, and limits of computer-aided pattern analysis (C@PA). Computational and Structural Biotechnology Journal 2021; 19: 3269 doi: 10.1016/j.csbj.2021.05.018
|
| 56 |
Michela Pasello, Anna Maria Giudice, Katia Scotlandi. The ABC subfamily A transporters: Multifaceted players with incipient potentialities in cancer. Seminars in Cancer Biology 2020; 60: 57 doi: 10.1016/j.semcancer.2019.10.004
|
| 57 |
Archana Thakur, Johnson Ung, Elyse N. Tomaszewski, Amy Schienschang, Timothy M. LaBrie, Dana L. Schalk, Lawrence G. Lum. Priming of pancreatic cancer cells with bispecific antibody armed activated T cells sensitizes tumors for enhanced chemoresponsiveness. OncoImmunology 2021; 10(1) doi: 10.1080/2162402X.2021.1930883
|
| 58 |
Raúl Ortíz, Francisco Quiñonero, Beatriz García-Pinel, Marco Fuel, Cristina Mesas, Laura Cabeza, Consolación Melguizo, Jose Prados. Nanomedicine to Overcome Multidrug Resistance Mechanisms in Colon and Pancreatic Cancer: Recent Progress. Cancers 2021; 13(9): 2058 doi: 10.3390/cancers13092058
|
| 59 |
Ka Iong Chan, Siyuan Zhang, Guodong Li, Yida Xu, Liao Cui, Yitao Wang, Huanxing Su, Wen Tan, Zhangfeng Zhong. MYC Oncogene: A Druggable Target for Treating Cancers with Natural Products. Aging and disease 2024; 15(2): 640 doi: 10.14336/AD.2023.0520
|
| 60 |
Louise Skau Rasmussen, Stine B. Winther, Inna M. Chen, Britta Weber, Lise Ventzel, Gabor Liposits, Julia Sidenius Johansen, Sönke Detlefsen, Ida Egendal, Susy Shim, Signe Christensen, Per Pfeiffer, Morten Ladekarl. A randomized phase II study of full dose gemcitabine versus reduced dose gemcitabine and nab-paclitaxel in vulnerable patients with non-resectable pancreatic cancer (DPCG-01). BMC Cancer 2023; 23(1) doi: 10.1186/s12885-023-11035-6
|
| 61 |
Maria Krchniakova, Jan Skoda, Jakub Neradil, Petr Chlapek, Renata Veselska. Repurposing Tyrosine Kinase Inhibitors to Overcome Multidrug Resistance in Cancer: A Focus on Transporters and Lysosomal Sequestration. International Journal of Molecular Sciences 2020; 21(9): 3157 doi: 10.3390/ijms21093157
|
| 62 |
Jana Kotulova, Katerina Lonova, Agata Kubickova, Jana Vrbkova, Pavla Kourilova, Marian Hajduch, Petr Dzubak. 2‑Cl‑IB‑MECA regulates the proliferative and drug resistance pathways, and facilitates chemosensitivity in pancreatic and liver cancer cell lines. International Journal of Molecular Medicine 2022; 49(3) doi: 10.3892/ijmm.2022.5086
|
| 63 |
Jing‐Quan Wang, Zhuo‐Xun Wu, Yuqi Yang, Qiu‐Xu Teng, Yi‐Dong Li, Zi‐Ning Lei, Khushboo A Jani, Neeraj Kaushal, Zhe‐Sheng Chen. ATP‐binding cassette (ABC) transporters in cancer: A review of recent updates. Journal of Evidence-Based Medicine 2021; 14(3): 232 doi: 10.1111/jebm.12434
|
| 64 |
Sarrah L. Hasanali, Daley S. Morera, Ronny R. Racine, Martin Hennig, Santu Ghosh, Luis E. Lopez, Marie C. Hupe, Diogo O. Escudero, Jiaojiao Wang, Huabin Zhu, Semih Sarcan, Ijeoma Azih, Michael Zhou, Andre R. Jordan, Martha K. Terris, Markus A. Kuczyk, Axel S. Merseburger, Vinata B. Lokeshwar. HYAL4-V1/Chondroitinase (Chase) Drives Gemcitabine Resistance and Predicts Chemotherapy Failure in Patients with Bladder Cancer. Clinical Cancer Research 2021; 27(15): 4410 doi: 10.1158/1078-0432.CCR-21-0422
|
| 65 |
Lisa Kater, Benjamin Kater, Michael A. Jakupec, Bernhard K. Keppler, Aram Prokop. KP772 overcomes multiple drug resistance in malignant lymphoma and leukemia cells in vitro by inducing Bcl-2-independent apoptosis and upregulation of Harakiri. JBIC Journal of Biological Inorganic Chemistry 2021; 26(8): 897 doi: 10.1007/s00775-021-01900-9
|
| 66 |
Anbin Wang, Haisu Dai, Yi Gong, Chengcheng Zhang, Junjie Shu, Yuandeng Luo, Yan Jiang, Wei Liu, Ping Bie. ANLN-induced EZH2 upregulation promotes pancreatic cancer progression by mediating miR-218-5p/LASP1 signaling axis. Journal of Experimental & Clinical Cancer Research 2019; 38(1) doi: 10.1186/s13046-019-1340-7
|
| 67 |
Qi Tang, Dan Yin, Yao Wang, Wenxuan Du, Yuhan Qin, Anni Ding, Hanmei Li. Cancer Stem Cells and Combination Therapies to Eradicate Them. Current Pharmaceutical Design 2020; 26(17): 1994 doi: 10.2174/1381612826666200406083756
|
| 68 |
Jonathan M. Moore, Eric L. Bell, Robert O. Hughes, Alastair S. Garfield. ABC transporters: human disease and pharmacotherapeutic potential. Trends in Molecular Medicine 2023; 29(2): 152 doi: 10.1016/j.molmed.2022.11.001
|